Healthcare / Medical Care FacilitiesThailand
$19.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $354.4M · quality 63.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3.0B
P/E
12.4x
↓EV/EBITDA
3.7x
↓ROE
9.8%
↑Gross Margin
26.9%
↓Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+1.7%
FCF CAGR
-19.2%
FCF margin
8.4%
FCF / Net income
0.72x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.37B · net income $276.8M · FCF $199.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.37B | $2.37B | $2.48B | $2.47B | $2.26B |
| Net Income | $276.8M | $276.8M | $360.7M | $387.7M | $300.6M |
| EBITDA | $526.0M | $526.0M | $620.4M | $650.7M | $556.7M |
| EPS | 1.73 | 1.73 | 2.25 | 2.42 | 1.88 |
| Gross Margin | 26.9% | 26.9% | 29.8% | 30.9% | 29.1% |
| Operating Margin | 13.6% | 13.6% | 17.3% | 19.1% | 16.4% |
| Net Margin | 11.7% | 11.7% | 14.5% | 15.7% | 13.3% |
| Balance Sheet | |||||
| Current Ratio | 4.20 | 4.20 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $199.6M | $199.6M | $354.4M | $406.1M | $377.8M |
| Returns | |||||
| ROE | 9.8% | 9.8% | 13.1% | 14.7% | 12.4% |
| Valuation | |||||
| P/E | 12.42 | 12.42 | 16.82 | 15.63 | 21.64 |
| EV/EBITDA | 3.67 | 3.67 | 8.43 | 7.93 | 9.94 |
| P/B | 1.08 | 1.08 | 2.20 | 2.30 | 2.68 |
| Growth & Yield | |||||
| Revenue Growth | -4.5% | -4.5% | 0.5% | 9.6% | — |
| EPS Growth | -23.1% | -23.1% | -7.0% | 28.7% | — |
| Dividend Yield | 4.7% | 4.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-0.9%
EPS terminal req.
$1.69
Spread vs growth
-22.3%
5Y implied EPS CAGR
3.4%
EPS terminal req.
$2.04
Spread vs growth
-26.5%
10Y implied EPS CAGR
6.6%
EPS terminal req.
$3.29
Spread vs growth
-29.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-20.1%
Start / end P/E
13.0x → 12.7x
EPS bridge
2.25 → 1.73
Residual
+0.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.